Recro Pharma, Inc. | Business Finance | Business Contracts

Underwriting Agreement relating to the Common Offering, dated as of December 12, 2022, by and between Societal CDMO, Inc. and RBC Capital Markets, LLC, as representative of the... (Filed With SEC on December 13, 2022)

Underwriting Agreement relating to the Preferred Offering, dated as of December 12, 2022, by and between Societal CDMO, Inc. and RBC Capital Markets, LLC, as representative of the... (Filed With SEC on December 13, 2022)

Purchase and Sale Agreement, dated as of December 9, 2022, by and between Societal CDMO Gainesville, LLC and Tenet Equity Funding SPE Gainesville, LLC (Filed With SEC on December 12, 2022)

Seventh Amendment to Credit Agreement, dated as of December 9, 2022, by and among Societal CDMO, Inc., certain subsidiaries of Societal CDMO, Inc., named as guarantors therein,... (Filed With SEC on December 12, 2022)

Credit Agreement, dated as of December 12, 2022, by Societal CDMO, Inc. in favor of RBC Capital Markets, LLC (Filed With SEC on December 12, 2022)

Purchase and Sale Agreement and Joint Escrow Instructions dated August 11, 2022, by and among Societal CDMO Gainesville, LLC, a Massachusetts limited liability company and Weekley... (Filed With SEC on August 16, 2022)

Unit Purchase Agreement, dated August 13, 2021, by and among Recro Pharma, Inc., IriSys, LLC, the Sellers (as defined therein), and IriSys, Inc. as the Sellers Representative (Filed With SEC on August 13, 2021)

Form of Subordinated Promissory Note (Filed With SEC on August 13, 2021)

Sixth Amendment to Credit Agreement, dated as of August 13, 2021, by and among Recro Pharma, Inc., certain subsidiaries of Recro Pharma, Inc., named as guarantors therein, the... (Filed With SEC on August 13, 2021)

Form of Non-Qualified Stock Option Inducement Award Agreement (Filed With SEC on August 9, 2021)

Form of Inducement Award Agreement for Restricted Stock Units (Filed With SEC on August 9, 2021)

Underwriting Agreement, dated as of May 12, 2021, by and between Recro Pharma, Inc. and William Blair & Company, L.L.C., as representative of the underwriters (Filed With SEC on May 13, 2021)

Form of Non-Qualified Stock Option Award Agreement (Filed With SEC on February 26, 2021)

Form of Award Agreement for Restricted Stock Units (Filed With SEC on February 26, 2021)

Second Amendment to Common Stock Purchase Agreement, by and between Aspire Capital Fund, LLC and Recro Pharma, Inc., dated February 26, 2021 (Filed With SEC on February 26, 2021)

Fifth Amendment to Credit Agreement and Investment Documents, dated as of February 19, 2021, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP (Filed With SEC on February 23, 2021)

Stock Issuance Agreement, dated as of February 19, 2021 by and between Recro Pharma, Inc., Athyrium Opportunities II Acquisition LP and Athyrium Opportunities III Acquisition LP (Filed With SEC on February 23, 2021)

Fourth Amendment to Credit Agreement and Investment Documents, dated as of November 5, 2020, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP (Filed With SEC on November 9, 2020)

First Amendment to Common Stock Purchase Agreement, by and between Aspire Capital Fund, LLC and Recro Pharma, Inc., dated August 7, 2020 (Filed With SEC on August 10, 2020)

Note dated May 12, 2020, between Recro Pharma, Inc. and PNC Bank, National Association (Filed With SEC on May 15, 2020)

Partial Assignment, Assumption and Bifurcation Agreement, dated November 20, 2019, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC, Recro Pharma, Inc. and... (Filed With SEC on November 26, 2019)

Third Amendment to Credit Agreement and Release Agreement, dated as of October 22, 2019, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP (Filed With SEC on November 8, 2019)

Agreement, dated March 25, 2019, by and among Recro Pharma, Inc., Engine Capital, L.P., Engine Jet Capital, L.P., Engine Investments, LLC, and Arnaud Ajdler (Filed With SEC on March 28, 2019)

Second Amendment to Credit Agreement and Investment Documents, dated February 28, 2019, by and among the Recro Pharma, Inc., the guarantors party thereto, the lenders party... (Filed With SEC on March 4, 2019)

Registration Rights Agreement, dated February 19, 2019, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC (Filed With SEC on February 19, 2019)

Common Stock Purchase Agreement, dated February 19, 2019, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC (Filed With SEC on February 19, 2019)

First Amendment to Credit Agreement and Investment Documents, dated December 28, 2018, by and among the Recro Pharma, Inc., the guarantors party thereto, the lenders party... (Filed With SEC on January 4, 2019)

Recro Pharma, Inc. (116) | Business Finance (27)